fda tirzepatide shortage update today says years-long is resolved, will give limited leeway to compounders FDA Confirms Lilly's GLP-1s Are

See Section 7 for full medication coding guidance

This accessibility reduces anxiety for patients experiencing side effects or needing guidance outside traditional working hours

PT is also prolonged in some patients with liver disease because of the presence of dysfibrinogenemia, an abnormal form of fibrinogen that does not clot normally, and that may predispose to thrombosis

Semaglutide (used in GLP-1 medications like Ozempic and Wegovy) is a peptide drug, and tesamorelin is an FDA-approved synthetic growth hormone-releasing factor analogue

Use of these drugs has surged: from 2019 to 2024 in the US, prescriptions for patients with obesity without diabetes rose by nearly 2,000%